| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/20/2006 | US20060159764 for delivery of nucleic acids for example; noncovalently associating molecules with the polyion in a solution outside a cell; adding a crosslinker that contains a disulfide bond and forms covalent linkages between moieties of the molecules in the presence of the polyion, to form a complex |
| 07/20/2006 | US20060159763 Osmotic device containing amantadine and an osmotic salt |
| 07/20/2006 | US20060159762 Stable pharmaceutical composition comprising an active substance in the form of solid solution |
| 07/20/2006 | US20060159761 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine |
| 07/20/2006 | US20060159760 Drug composition having active ingredient adhered at high concentration to spherical core |
| 07/20/2006 | US20060159759 Tablet containing water-absorbing amino acid |
| 07/20/2006 | US20060159758 Coating composition for taste masking coating and methods for their application and use |
| 07/20/2006 | US20060159757 Pharmaceutical composition for controlled release of beta-lactam antibiotics in combination with beta-lactamase inhibitors |
| 07/20/2006 | US20060159756 Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor |
| 07/20/2006 | US20060159755 Method for producing a controlled release preparation |
| 07/20/2006 | US20060159754 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 07/20/2006 | US20060159753 Matrix type sustained-release preparation containing basic drug or salt thereof |
| 07/20/2006 | US20060159752 Extended release matrix tablets |
| 07/20/2006 | US20060159751 Controlled release pharmaceutical compositions of carbidopa and levodopa |
| 07/20/2006 | US20060159750 Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| 07/20/2006 | US20060159749 Mesalamine inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices |
| 07/20/2006 | US20060159748 Oral immediate release formulation of a poorly water-soluble active substance |
| 07/20/2006 | US20060159747 Telmisartan and hydrochlorothiazide combination therapy |
| 07/20/2006 | US20060159746 Compositions comprising fatty acids and amino acids |
| 07/20/2006 | US20060159745 Probiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 07/20/2006 | US20060159744 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 07/20/2006 | US20060159743 Administering once daily; improving patient compliance |
| 07/20/2006 | US20060159742 Stabilized individually coated ramipril particles, compositions and methods |
| 07/20/2006 | US20060159741 Pharmaceutical compositions comprising amoxicillin and clavulanic acid |
| 07/20/2006 | US20060159740 Hydrophobic photosensitizer formulations for photodynamic therapy |
| 07/20/2006 | US20060159739 Liposomes containing an entrapped compound in supersaturated solution |
| 07/20/2006 | US20060159738 Cationic liposomes and methods of use |
| 07/20/2006 | US20060159737 Pharmaceutical compositions for local administration |
| 07/20/2006 | US20060159736 Liposome formulations of boronic acid compounds |
| 07/20/2006 | US20060159735 Method of reclaiming drug compound from liposomal drug manufacturing stream |
| 07/20/2006 | US20060159731 Multi-layer collagenic article useful for wounds healing and a method for its production thereof |
| 07/20/2006 | US20060159730 Cosmetic or dermatological article comprising a medium that is soluble in water |
| 07/20/2006 | US20060159729 Dissolvable pads for solution delivery to a surface |
| 07/20/2006 | US20060159722 Layered aligned polymer structures and methods of making same |
| 07/20/2006 | US20060159715 Conjugate of fine porous particles with polymer molecules and the utilization thereof |
| 07/20/2006 | US20060159713 Bendamustine pharmaceutical compositions |
| 07/20/2006 | US20060159712 Lipid particles comprising bioactive agents, methods of preparing and uses thereof |
| 07/20/2006 | US20060159711 Therapeutic agent for hemorrhoidal disease |
| 07/20/2006 | US20060159679 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/20/2006 | US20060159663 Growth factor encapsulation system for enhancing bone formation |
| 07/20/2006 | US20060159657 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
| 07/20/2006 | US20060159656 Formulations for IL-11 |
| 07/20/2006 | US20060159653 Stabilized preparation containing protein |
| 07/20/2006 | US20060159638 O/W emulsions comprising micronized biologically active agents |
| 07/20/2006 | US20060159632 Drug formulation for mouth or pharynx comprising local anesthetic |
| 07/20/2006 | US20060159629 Perforated; standard particle size; nonaggregating; flowability, dispersibility; lower dosage inhalants |
| 07/20/2006 | US20060159628 Nanoparticulate benzothiophene formulations |
| 07/20/2006 | US20060159624 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; sleep disorders |
| 07/20/2006 | US20060159603 combining a metal compound (AgNO3) with a solution that comprises a polyol (ethylene glycol)and a substance( polyvinypyrrolidone homo or copolymer) that is capable of being adsorbed on the nanoparticles. The nanoparticles are precipitated by adding a nanoparticle-precipitating liquid (acetone) |
| 07/20/2006 | US20060158725 Laser projector |
| 07/20/2006 | US20060156986 Modification method of surface layer of molded resin article, and modification apparatus of surface layer of molded resin article |
| 07/20/2006 | DE10227938B4 Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung A pharmaceutical preparation, processes for their preparation and their use |
| 07/20/2006 | DE102005001332A1 Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren Two-piece capsule with pre-closure for holding pharmaceutical preparations for powder inhalers |
| 07/20/2006 | CA2594894A1 Method for delivering interferon-.beta. |
| 07/20/2006 | CA2594675A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/20/2006 | CA2594328A1 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
| 07/20/2006 | CA2593582A1 Bendamustine pharmaceutical compositions |
| 07/20/2006 | CA2593272A1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 07/20/2006 | CA2593204A1 Two-piece capsule comprising a preliminary closure for accommodating pharmaceutical preparations for powder inhalers |
| 07/20/2006 | CA2593111A1 Formulations for coated microprojections having controlled solubility |
| 07/20/2006 | CA2592542A1 Dosage form for treating gastrointestinal disorders |
| 07/20/2006 | CA2588925A1 Solid preparation comprising reduced coenzyme q10 and process for production of the same |
| 07/20/2006 | CA2493947A1 Arthro gel and syner gel |
| 07/19/2006 | EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad) |
| 07/19/2006 | EP1681065A1 Water-based composition undergoing reversible thermogelation |
| 07/19/2006 | EP1681059A1 Pharmaceutical composition containing prostaglandin |
| 07/19/2006 | EP1681054A1 Therapeutic agent for keratoconjunctiva disorder |
| 07/19/2006 | EP1681053A1 Composition containing reduced coenzyme q |
| 07/19/2006 | EP1681052A1 Solid pharmaceutical dosage forms for reducing the bioavailability food effect |
| 07/19/2006 | EP1681051A1 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers |
| 07/19/2006 | EP1681050A1 Dispersible sustained release pharmaceutical compositions |
| 07/19/2006 | EP1681049A1 Pharmaceutical composition and dosage form fast-disintegrating in the mouth , and process to prepare it |
| 07/19/2006 | EP1681048A1 Orally disintegrating composition of olanzapine or donepezil |
| 07/19/2006 | EP1680446A2 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
| 07/19/2006 | EP1680412A1 Tocopheryl polyethylene glycol succinate articles and process for preparing tpgs articles |
| 07/19/2006 | EP1680212A2 Reagent-containing membranes and laminates and methods of their preparation |
| 07/19/2006 | EP1680178A2 System and method for transdermal vaccine delivery |
| 07/19/2006 | EP1680148A1 Hydrogel-containing medical articles and methods of using and making the same |
| 07/19/2006 | EP1680142A2 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis |
| 07/19/2006 | EP1680134A1 Compositions and uses therof |
| 07/19/2006 | EP1680130A2 Desensitization of complement activation using monocyte/macrophage inhibitory compounds |
| 07/19/2006 | EP1680128A1 Myo-inositol hexaphosphate for topical use |
| 07/19/2006 | EP1680121A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 07/19/2006 | EP1680110A1 Once daily dosage forms of trospium |
| 07/19/2006 | EP1680100A1 Compositions of quaternary ammonium containing bioavailability enhancers |
| 07/19/2006 | EP1680098A1 Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
| 07/19/2006 | EP1680097A1 Preparations for topical application and methods of delivering an active agent to a substrate |
| 07/19/2006 | EP1680096A1 New formulation for retinoid-containing soft gelatin capsules |
| 07/19/2006 | EP1680095A2 Valsartan containing formulation |
| 07/19/2006 | EP1680094A1 Controlled release formulations of opioid and nonopioid analgesics |
| 07/19/2006 | EP1680093A1 Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and l-arginine alpha-ketoglutarate |
| 07/19/2006 | EP1680092A2 Pharmaceutical formulation with improved stability |
| 07/19/2006 | EP1680091A1 A solid dosage form comprising a fibrate |
| 07/19/2006 | EP1680090A2 Process for production of essentially solvent-free small particles |
| 07/19/2006 | EP1680089A1 Composition comprising biodegradable hydrating ceramics for controlled drug delivery |
| 07/19/2006 | EP1680088A1 Antibiotic compositions |
| 07/19/2006 | EP1680087A1 Nanoparticles for drug delivery |
| 07/19/2006 | EP1680086A2 A solid dosage form comprising a fibrate and a statin |
| 07/19/2006 | EP1680085A1 A novel cationic lipopolymer as a biocompatible gene delivery agent |
| 07/19/2006 | EP1680084A2 A multiple route medication for the treatment of rhinitis and asthma |